Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Send Away Test for Oncotype DX Breast Recurrence Score

Gloucestershire Hospitals NHS Foundation Trust

This public procurement record has 1 release in its history.

Award

08 Oct 2026 at 15:29

Award Notice
Summary of the contracting process

Gloucestershire Hospitals NHS Foundation Trust commissioned Oncotype DX Breast Recurrence Score testing, a pathology service using a genomic assay to provide personalised information about breast cancer biology. The test is intended to help guide chemotherapy decisions, particularly for patients with lymph-node-positive breast cancer, and can help identify patients who may avoid unnecessary chemotherapy. The service is for the Trust’s patients. The work is a specialist laboratory testing service rather than a supply of general pathology services; its focus is genomic assessment of breast tumours and recurrence risk. The Trust is the buying organisation, and the test supports clinical decision-making about treatment.

The procurement is complete and the contract is active. The Trust awarded the work to Exact Sciences UK Ltd under the Health Care Services Provider Selection Regime, using Direct Award A because the Trust identified Exact Sciences as the only provider of this test. The contract was signed on 7 October 2026 and runs from 1 July 2027 to 30 June 2028, with a value of £229,500. The stated evaluation criterion was price. The procurement describes a single lot, although that lot is marked cancelled; the award and contract are recorded as active. One bid was recorded. The direct award was made without a prior call for competition.

This award indicates demand for a highly specialised genomic assay that informs treatment decisions for breast cancer patients, rather than for routine pathology testing. A supplier seeking to compete if this requirement returns would need to provide the Oncotype DX Breast Recurrence Score test or demonstrate an equivalent capability accepted by the Trust, with laboratory expertise in genomic analysis and reliable reporting of personalised tumour biology and recurrence-risk results. The buyer’s stated rationale was that Exact Sciences was the only provider of this type of test, so establishing a credible alternative would be central to competing. Suppliers would also need to support the clinical use of results in decisions about chemotherapy, including for patients with lymph-node-positive disease.

How relevant is this notice?

Notice Information

Notice Title

Send Away Test for Oncotype DX Breast Recurrence Score

Notice Description

Provision of Oncotype DX Breast Recurrence Score via a genomic assay that provides a personalised insight into an individual patient's breast cancer biology.

Lot Information

Lot 1

Oncotype DX Breast Recurrence Score is a genomic assay that provides a personalised insight into an individual patient's breast cancer biology. The Oncotype DX Breast Recurrence Score test addresses the issue overtreatment with chemotherapy, particularly for patients with lymph node-positive breast cancer. In providing a more precise information about tumour biology, it allows many patients to avoid unnecessary chemotherapy. Due to Exact Science being the only provider of this test, the contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023 Direct Award A. The lifetime of the contract is PS229,500 from 1st July 2027 until 30th June 2028

Procurement Information

This contract was awarded via the Provider Selection Regime under Direct Award A due to Exact Science being the only provider of this type of test.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-078403
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/095328-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85111800 - Pathology services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£229,500 £100K-£500K

Notice Dates

Publication Date
8 Oct 20262 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Gloucestershire Hospitals NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
GLOUCESTER
Postcode
GL53 7AN
Postcode Area
Gloucester
Country
England
Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK7 Gloucestershire and Wiltshire
Small Region (ITL 3)
TLK73 Gloucestershire CC
Delivery Location
TLK13 Gloucestershire CC
Local Authority
Cheltenham
Electoral Ward
College
Westminster Constituency
Cheltenham

Supplier Information

Number of Suppliers
1
Supplier Name

Exact Sciences UK, Ltd.

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...